Transgenic Mammals Having Human IG LOCI Including Plural Vh and Vk Regions and Antibodies Produced Therefrom

Details for Australian Patent Application No. 2005202768 (hide)

Owner Amgen Fremont Inc.

Inventors Mendez, Michael; Green, Larry; Kucherlapati, Raju; Jakobovits, Aya; Klapholz, Sue

Agent Cullen & Co

Pub. Number AU-B-2005202768

Parent 24501

Filing date 24 June 2005

Wipo publication date 21 July 2005

Acceptance publication date 13 March 2008

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 July 2005 Complete Application Filed

21 July 2005 Application Open to Public Inspection

  Published as AU-B-2005202768

2 August 2007 Assignment before Grant

  Abgenix, Inc. The application has been assigned to Amgen Fremont Inc.

13 March 2008 Application Accepted

  Published as AU-B-2005202768

10 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202769-Acyclic and Cyclic Amine Derivatives

2005202767-Autologous T-cell vaccines materials and methods